Endocan Corp (OP: ENDO )
0.0308 USD +0.0008 (+2.67%) Streaming Delayed Price Updated: 2:28 PM EDT, Jun 18, 2021 Add to My Watchlist
All news about Endocan Corp
Thermic Science Proudly Receives OTC Markets Registration Confirmation, Makes Payment of Initial Exchange Fees to Begin Uploading its Financials and Reporting Requirements to Bring the Company Current
June 01, 2021
RIGHT ON BRANDS PAYS OFF CONVERTIBLE DEBT HOLDERS FILES 10 K
April 01, 2021
The Cannabis Science Inc., Share Exchange is Underway! OMNICANNA Files Name Change to Thermic Science International Corporation and Files SPAC Share Structure to Bring Cannabis Science and Recent Acqu
March 31, 2021
OMNICANNA/Thermic Appoints Mr. Hendrik Schutte as Research Director of Electrical Components, Sales & Development (DECS), Renewable Thermic Solid State Battery Power Units and Thermic Self-Generating
March 19, 2021
OMNICANNA/Thermic Sciences Acquires 100% of Another European Groundbreaking Technology; Litcoat Electroluminescent Paint, Known as Multi-Colored Electrical Lighting Paint for Cars, Boats, Motorcycles,
March 08, 2021
OMNICANNA/Thermic Sciences Identifies Key Retail and Warehouse Manufacturing Facilities in North America for the Thermic Product Launch, Retail and Wholesale Distribution, OEM Manufacturing, and New P
January 27, 2021
Omnicanna Successfully Submits www.ihemp.omnicanna.com to The National Institute of Food and Agriculture, U.S. Department of Agriculture, Competitive Grants Program for Sustainable Agricultural System
January 15, 2021
OMNICANNA Acquires 100% Shares of Thermic Coating Systems, Ltd., of the UK, Manufacturing in UK, Netherlands & France
October 02, 2020
From EIN Presswire
Stocks That Hit 52-Week Lows On Thursday
January 30, 2020
Thursday's morning session saw 179 companies set new 52-week lows. Areas of Interest: Exxon Mobil(NYSE: XOM)was ...
Stocks That Hit 52-Week Lows On Tuesday
November 05, 2019
Before 10 a.m. ET Tuesday, 78 stocks hit new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to ...
Stocks That Hit 52-Week Lows On Wednesday
August 21, 2019
On Wednesday morning, 85 companies hit new 52-week lows. Areas of Interest: Japan Tobacco (OTC: JAPAF) is the largest company ...
Endo Stock Surges 17% Following Settlement Agreement
August 20, 2019
Endo To Enter A Year Of Recovery Following FDA Request To Pull Opana ER Off The Market
June 09, 2017
Shares of Endo International plc - Ordinary Shares (NASDAQ: ENDP) were trading lower by more than 10 percent Friday morning in reaction ...
Could Trump Tax Cut Plans, Republican Congress Spur Biotech M&A?
November 10, 2016
Donald Trump could create an M&A-friendly tax scenario, prodding more acquisitions from the small- and mid-cap biotech pool.
The Market In 5 Minutes: Jobs Numbers, Big Earnings Close The Week
November 04, 2016
Macro Focus Futures for the Dow Jones Industrial Average dropped 20 points to 17,831.00, while the Standard & Poor’s ...
Up with Endo, Down with Allergan…Sort Of
July 17, 2015
Downgrading a stock from a Top Pick to Outperform doesn’t seem like much of a shift, thus Allergan (AGN) is barely moving in per market action, falling just 0.2% to $316.80 at today’s opening bell. In...
OmniCanna (ENDO) Today Launches www.TheHempery.com "Specialized Hemp Based Health and Wellness" Online Store
May 20, 2015
OmniCanna Health Solutions, Inc. (ENDO) Names Greta Gaines as CEO & President as Company Prepares for US Release of 'The Hempery' Product Line on May 20, 2015
May 18, 2015
Valeant vs Endo: Who Will Win the Fight for Salix
March 12, 2015
The fight is one. Yesterday, Endo International (ENDP) announced it is bidding $175 a share in cash and stock for Salix Pharmaceuticals (SLXP), looking to interrupt the$158-a-share deal Valeant...
Six Degrees of a Drug Deal: Endo Battles Valeant for Salix
March 11, 2015
I just love it when a drug industry acquisition starts sounding like a round from the drinking game “six degrees of separation.” The Wall Street Journal is reporting that yet another drug maker is...
Endo to pay $25M for nasal testosterone replacement therapy
November 24, 2014
Endo International made a bigger push into the testosterone replacement therapy market Monday by agreeing to acquire the rights to Natesto for $25 million...
The Dow Jones Industrial Average (DJIA) plummeted 334 points Thursday, giving back all of yesterday's gains. U.S. markets tumbled on lingering concerns about global economic growth and after St. Louis...
From Money Morning
After rebuffing an unsolicited takeover attempt last month, Auxilium Pharmaceuticals Inc. decided to accept a revised buyout offer from Endo International in a deal involving two biopharmaceutical...
Endo reaches deal to resolve remaining vaginal mesh product claims
October 01, 2014
Endo International has reached master settlement agreements with several of the remaining leading plaintiffs’ law firms to resolve remaining claims relating to vaginal mesh products sold by its...
Endo's $2.2B offer for Auxilium is not good enough, board says
September 22, 2014
Auxilium Pharmaceuticals Inc.’s board of directors unanimously reaffirmed its position Monday that the company should continue moving forward with its plans to merge with QLT Inc...
Endo makes unsolicited $2.2B offer for Auxilium
September 17, 2014
Endo International has made a $2.2 billion offer to buy Auxilium Pharmaceuticals in a deal that would join together two of the region's largest life sciences companies...
Endo launches generic testosterone replacement gel
September 08, 2014
Endo International on Monday launched a generic version of its testosterone gel Fortesta, a treatment for adult males diagnosed with hypogonadism — a condition where the body's sex glands produce...